Tirzepatide decreases waist-to-height ratio in humans.
“At time of weight nadir, the proportion with high WHtR had reduced to 43%, 42%, and 44%, while by the end of the study 45%, 59%, and 68% of participants had high WHtR in the <5%, 5% to <10%, and ≥10% weight regain from nadir groups, respectively.”
Tirzepatide decreases waist-to-height ratio in humans (women with baseline BMI under 35 kg/m2, across reproductive stage subgroups) (30% to 52% reached WHtR of 0.49 or less).
“30% to 52% of women among the reproductive stage subgroups who had baseline BMI < 35 kg/m2 reached WHtR ≤ 0.49 (low central adiposity) with tirzepatide.”
Human trialwomen with baseline BMI under 35 kg/m2, across reproductive stage subgroups15 mg or maximum tolerated dosefemales
Physical activity promotion program decreases waist-to-height ratio in humans.
“For the 1st vs. 3rd pairwise comparison, significant differences were demonstrated in WHtR, HDL-C, cognitive function for attention and executive function (i.e., SCWT), and MVPA ≥ 150 min/wk, and sitting time.”
Moderate-to-vigorous leisure-time physical activity is linked with lower waist-to-height ratio in older adults at high cardiovascular risk (-0.021 to -0.026).
Waist-to-height ratio is linked with incident heart failure in humans (mediation of the association between ultra-processed food intake and heart failure) (approximately 51% mediated).
“waist-to-height ratio mediated approximately 51% of the association between UPF intake and total HF”
Humansmediation of the association between ultra-processed food intake and heart failure
Waist-to-height ratio is linked with higher fatty liver classification ROC AUC in humans (ROC AUC to 0.867; paired difference 0.00163 (95% CI −0.00009 to 0.00337)).
“Adding WHtR to BMI plus TyG increased the ROC AUC to 0.867, a paired difference of 0.00163 (95% CI, − 0.00009 to 0.00337).”
HumansWHtR added to BMI plus TyG; cross-validated models including age, sex, systolic blood pressure and diastolic blood pressurelivern = 3,469
Socioeconomic disparities in prevalent cardiovascular disease
→mediatesin humans1
1 study
Waist-to-height ratio is linked with socioeconomic disparities in prevalent cardiovascular disease in humans (Counterfactual mediation analysis adjusted for age, sex, and ethnicity) (10.4% mediated proportion).
“Among adiposity measures, WHtR demonstrated the largest contribution (10.4%), exceeding waist circumference (5.0%), body mass index (4.6%), and CAP (1.4%).”
HumansCounterfactual mediation analysis adjusted for age, sex, and ethnicityn = 4,772
Waist-to-height ratio is linked with better diabetes prediction discrimination in humans (Adding nonlinear waist-to-height ratio to the prediction model) (Reported C-index=0.0134).
“Adding nonlinear WHtR improved cross-validated discrimination, most notably for diabetes (C-index=0.0134).”
HumansAdding nonlinear waist-to-height ratio to the prediction model
Waist-to-height ratio was not clearly linked with microalbuminuria in humans (Strict normotension and ADA-defined prediabetes) (OR 1.00, 95% CI 0.56–1.79).
“TG/HDL (0.96, 0.88–1.06) and WHtR (1.00, 0.56–1.79) were also non-significant.”
HumansStrict normotension and ADA-defined prediabetesn = 976
Waist-to-height ratio is linked with cardiovascular disease in humans (44% of the total association).
“waist-to-height ratio (β: 0.012; CI: 0.007-0.017) and interleukin (IL)-6 (β: 0.003; CI: 0.001-0.006) significantly mediated the association between UPF intake and incident CVD”
Waist-to-height ratio is associated with hypertension in humans (Per 0.1-unit higher waist-to-height ratio) (aPR 1.24 per 0.1 unit, 95% CI 1.13–1.37).
“Greater waist circumference (aPR 1.10 per 10 cm, 95% CI 1.02–1.20) and waist-to-height ratio (aPR 1.24 per 0.1 unit, 95% CI 1.13–1.37) were similarly associated with hypertension.”
Waist-to-height ratio is linked with a higher risk of hypertension in individuals with metabolic dysfunction (HR 1.876, 95% CI 1.411–2.495).
“elevated WHtR (HR = 1.876,95%CI, 1.411–2.495; P = 0.0003), TyG index (HR = 1.313, 95% CI: 1.024-1.684; P = 0.0317), and HOMA-β (HR = 1.319, 95% CI: 0.974-1.786; P = 0.0389) were significantly associated with an earlier onset of hypertension.”
Waist-to-height ratio is linked with a higher risk of hypertension in humans (above WHtR = 0.443) (HR 1.82, 95% CI 1.68–1.96).
“above the cut point, each 0.1-unit increase in WHtR was associated with an 82% increased risk of developing hypertension (HR = 1.82, 95% CI: 1.68–1.96).”
Waist-to-height ratio is linked with a higher risk of hypertension in humans (2021-2023 NHANES cycle) (OR: 1.82; 95% CI: 1.49, 2.22, P < 0.001).
“WHtR-high fat was associated with elevated BP [odds ratio (OR): 1.49; 95% confidence interval (CI): 1.04, 2.12, P < 0.001] and hypertension (OR: 1.82; 95% CI: 1.49, 2.22, P < 0.001)”
Waist-to-height ratio is linked with a higher risk of hypertension in humans (multivariable logistics regression model) (OR: 7.89 (95% CI: 2.10-29.67)).
“WHtR was closely related to new-onset hypertension in a multivariable logistics regression mode [OR: 7.89 (95% CI: 2.10-29.67)]”
Waist-to-height ratio predicts metabolic syndrome in humans (dOR 7.65 (95% CI: 6.00, 9.75)).
“As reflected by the dOR, WHtR (7.65; 95% CI: 6.00, 9.75) performed better than BMI (5.17; 95% CI: 4.75, 5.62) and WC (5.77; 95% CI: 4.60, 7.25) in screening for MetS among older adults”
Waist-to-height ratio is associated with mortality in humans (Korean men; Q1 versus Q5; fully adjusted models) (Q1 versus Q5: aHR 1.27, 95% CI 1.13–1.42).
“for WHtR among men, adjusted hazard ratio [aHR] of all-cause mortality:1.27, 95% CI 1.13–1.42 for Q1 vs. Q5”
HumansKorean men; Q1 versus Q5; fully adjusted models2009–2019males
Waist-to-height ratio is linked with a higher risk of mortality in humans (adjusted for BMI and other covariates (≥0.55 vs. < 0.50)) (RR 1.23, 95% CI 1.17-1.29).
“WtHR (≥0.55 vs. < 0.50) was positively associated with all-cause mortality risk in women (RR = 1.23, 95% CI 1.17-1.29)”
Humansadjusted for BMI and other covariates (≥0.55 vs. < 0.50)females
Waist-to-height ratio is associated with type 2 diabetes in humans (OR 2.739, 95% CI 2.293-3.271).
“Compared with the lowest BMI, WC, WHR, and WHtR quartiles, ORs of the highest quartiles were 2.131 (95% CI: 1.465-3.099), 1.752 (95% CI: 1.270-2.417), 1.342 (95% CI: 1.072-1.678), 2.739 (95% CI: 2.293-3.271) in men”
Diabetes, metabolic syndrome and obesity : targets and therapy·
Waist-to-height ratio predicts type 2 diabetes in humans (high cardiovascular risk).
“The AUCs for the waist-to-height ratio and waist circumference were significantly higher than the AUCs for BMI or weight for type-2 diabetes, hyperglycemia, atherogenic dyslipidemia and metabolic syndrome.”
Waist-to-height ratio is associated with cardiovascular disease in humans (CHARLS; elevated WHtR/normal HbA1c versus normal WHtR/normal HbA1c) (HR 1.37, 95% CI 1.21–1.56).
“In CHARLS, elevated WHtR/normal HbA1c was also positively associated with CVD (HR 1.37, 95% CI 1.21–1.56)”
HumansCHARLS; elevated WHtR/normal HbA1c versus normal WHtR/normal HbA1c2011–2018n = 7,712
Waist-to-height ratio is linked with a higher risk of cardiovascular disease in humans (WHtR + TyG approach, highest-risk group vs reference) (HR 5.12).
“The WHtR + TyG approach demonstrated a consistent dose-response pattern, with HRs of 2.22, 2.75, and 5.12 for ascending risk groups.”
HumansWHtR + TyG approach, highest-risk group vs referencen = 1,808
Waist-to-height ratio is linked with a higher risk of cardiovascular disease in humans (without baseline CVD) (HR = 1.271, 95% CI: 1.111-1.455).
“Elevated WHtR alone (HR = 1.271, 95% CI: 1.111-1.455) and elevated SBP alone (HR = 1.392, 95% CI: 1.240-1.564) were each associated with a higher risk of incident CVD.”
Waist-to-height ratio predicts body mass index in humans.
“Quantile regression analyses showed that WHtR and WC were strong and consistent predictors of BMI in all quantiles, with effect sizes increasing at higher levels of BMI.”
International journal of environmental research and public health·
Waist-to-height ratio is associated with body mass index in humans.
“Significant positive correlation was determined between WtHR and body mass index (BMI), WC, hip circumference (HC), neck circumference (NC), mid-upper arm circumference (MUAC), calf circumference (CC), and the weight-adjusted waist index (WWI)”
Waist-to-height ratio is associated with cardiometabolic multimorbidity in humans (Per SD increment in waist-to-height ratio) (OR 1.61 per SD increment; 95% CI 1.58–1.65).
“WHtR (OR, 1.61; 95% CI, 1.58-1.65) were more significantly associated with a higher prevalence of CMM than BMI (OR, 1.55; 95% CI, 1.52-1.58)”
HumansPer SD increment in waist-to-height ration = 101,973
Waist-to-height ratio is associated with metabolic dysfunction-associated steatotic liver disease in lowest vs highest WHtR quartile in validation cohort (2.15% to 36.93%).
“weighted lean MASLD prevalence increased from 2.15% in the lowest WHtR quartile to 36.93% in the highest (P for trend <0.001).”
Humansin lowest vs highest WHtR quartile in validation cohort
Waist-to-height ratio is linked with a higher risk of metabolic dysfunction-associated steatotic liver disease in adults with normal BMI (OR 1.16, 95% CI 1.10-1.22 per 0.01 increase).
“Each 0.01 increase in WHtR was associated with higher odds of prevalent lean MASLD after multivariable adjustment (odds ratio 1.16, 95% confidence interval 1.10-1.22; P = 0.009).”
Waist-to-height ratio predicts metabolic dysfunction-associated steatotic liver disease in humans (medical staff; gender-stratified analysis) (AUC 0.840 in females and 0.777 in males; optimal cutoffs 0.496 and 0.508, respectively).
“ROC curve analysis indicated that WHtR was a superior predictor when stratified by gender(females: AUC = 0.840; males: AUC = 0.777)”
Humansmedical staff; gender-stratified analysisfemale and male, analyzed separatelys
Waist-to-height ratio is associated with metabolic dysfunction-associated steatotic liver disease in humans (medical staff) (OR 2.747, 95% CI 1.191–6.337).
“BMI (OR = 1.295, 95% CI: 1.074-1.563) and WHtR (OR = 2.747, 95% CI: 1.191-6.337) significantly associated with NAFLD.”
Waist-to-height ratio is associated with low disease activity to remission in humans (WHtR <0.53 threshold reached by week 72) (odds ratio 2.31 (p < 0.001)).
“with an odds ratio of 2.31 (p < 0.001) compared to those who did not reach this target”
Human trialWHtR <0.53 threshold reached by week 72baseline to week 72
Obesity with poor muscle health was linked to 2.54 times the odds of developing knee arthritis with symptoms over six years compared with people with obesity alone.Obesity with poor muscle health was linked to 2.54 times the odds of developing knee arthritis with symptoms over six years compared with people with obesity alone.